{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:00:37Z","timestamp":1758981637169},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>Anti-cardiolipin antibodies of IgG class were found in 48% of intravenous drug users, 38% of homosexuals and 14% of heterosexuals (with no other risk factor) infected with HIV. Anti-cardiolipin antibodies were not increased in HIV-negative heterosexual partners of HIV-infected patients, but mildly elevated levels were detected in HIV-negative drug users, relative to healthy controls unselected for HIV status. Among HIV infected drug users, anti-cardiolipin antibodies were more common in men (P=0.01). Anti-cardiolipin antibodies were not associated with thrombocytopenia, Pneumocystis carinii pneumonia, disease progression or clinical stage. Anti-cardiolipin antibodies appear to be another non-specific marker of HIV infection which may be particularly common in male intravenous drug users infected with the virus.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb03328.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T16:56:40Z","timestamp":1280163400000},"page":"263-266","source":"Crossref","is-referenced-by-count":29,"title":["Anti-cardiolipin antibodies and HIV infection"],"prefix":"10.1093","volume":"81","author":[{"given":"C","family":"MACLEAN","sequence":"first","affiliation":[{"name":"Blood Transfusion Centre, Royal Infirmary, Edinburgh, Scotland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"FLEGG","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, City Hospital, Edinburgh, Scotland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D C","family":"KILPATRICK","sequence":"additional","affiliation":[{"name":"Blood Transfusion Centre, Royal Infirmary, Edinburgh, Scotland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713333628800_b1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","article-title":"Hydrallazine-induced systemic lupus erythematosis: influence of HLA-DR and sex on susceptibility","volume":"i","author":"Batchelor","year":"1980","journal-title":"Lancet"},{"key":"2022011713333628800_b2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-105-2-234","article-title":"Classification system for human T-lymphotropic virus type III\/lymphadenopathy-associated virus infections","volume":"105","author":"Centers for Disease Control","year":"1986","journal-title":"Ann. intern. Med"},{"key":"2022011713333628800_b3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-104-2-175","article-title":"Circulating coagulation inhibition in the acquired immunodeficiency syndrome","volume":"104","author":"Cohen","year":"1986","journal-title":"Ann. intern. Med"},{"key":"2022011713333628800_b4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jcp.42.6.629","article-title":"Lupus anticoagulant, anticardiolipin antibodies and human immunodeficiency virus in haemophilia","volume":"42","author":"Cohen","year":"1989","journal-title":"J. clin. Pathol"},{"key":"2022011713333628800_b5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(89)91658-9","article-title":"Anticardiolipin antibodies in viral infection","volume":"i","author":"Colaco","year":"1989","journal-title":"Lancet"},{"key":"2022011713333628800_b6","first-page":"289","article-title":"False positive ELISA tests for anti-cardiolipin antibodies in sera from patients with repeated abortion, rheumatological disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion","volume":"73","author":"Cowchock","year":"1988","journal-title":"Clin. exp. Immunol"},{"key":"2022011713333628800_b7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJM198605083141913","article-title":"Lupus anticoagulant and AIDS","volume":"314","author":"Gold","year":"1986","journal-title":"N. Engl. J. Med"},{"key":"2022011713333628800_b8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/anr.1780320627","article-title":"Hypergammaglobulinemia and the anti-cardiolipin antibody test","volume":"32","author":"Hughes","year":"1989","journal-title":"Arthritis Rheumat"},{"key":"2022011713333628800_b9","first-page":"4298","article-title":"Circulating anticoagulant in the acquired immunodeficiency syndrome","volume":"107","author":"Le Frer","year":"1987","journal-title":"Ann. intern. Med"},{"key":"2022011713333628800_b10","first-page":"738","article-title":"Measurement of anti-cardiolipin antibodies by an enzyme-linked immunoabsorbent assay (ELISA): standardization and quantitation of results","volume":"62","author":"Loizou","year":"1985","journal-title":"Clin. exp. Immunol"},{"key":"2022011713333628800_b11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(87)93019-4","article-title":"Autoimmunity to cardiolipin in infectious mononucleosis","volume":"ii","author":"Misra","year":"1987","journal-title":"Lancet"},{"key":"2022011713333628800_b12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00916816","article-title":"Anti-cardiolipin antibodies in homosexual men: prevalence and lack of association with human immunodeficiency virus (HIV) infection","volume":"9","author":"Mulhall","year":"1989","journal-title":"J. clin. Immunol"},{"key":"2022011713333628800_b13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0090-1229(82)90166-0","article-title":"Reactivity of anti-histone antibodies induced by procainamide and hydralazine","volume":"25","author":"Portnova","year":"1982","journal-title":"Clin. Immunol. Immunopathol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb03328.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/2\/263\/42217567\/j.1365-2249.1990.tb03328.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/2\/263\/42217567\/j.1365-2249.1990.tb03328.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T13:39:18Z","timestamp":1642426758000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/81\/2\/263\/6488757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb03328.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,8]]},"published":{"date-parts":[[1990,8]]}}}